Periodic reports

Although the reporting period covers approximately 12 years, the most detailed reporting has been implemented by most of the licensees since 1984 when the new LER rule came into effect and fewer component failures were reported to the LER system. One should note that no human-error-related data are included in the data banlc except for actions that cause brolcen hardware. 

Annual Report = periodic reports for licensed biological products (for NDAs Form FDA-2252 should be used as required in 21 CFR 314.81 (b)(2)) ... 

P. Somasundaran. Surfactant loss control in chemical flooding spectroscopic and calorimetric study of adsorption and precipitation on reservoir minerals—annual report for the reporting period September 30, 1992 to September 30, 1993. US DOE Fossil Energy Rep DOE/BC/14884-5, Columbia Univ, 1994. 

International Union of Pure and Applied Chemistry (lUPAC). TUPAC Periodic Table of the Elements. Available online. URL http //www.iupac.org/reports/periodic table/IUPAC Periodic Table-3Oct05.pdf... 

Several useful specialized reviews have appeared during the reporting period of this chapter. The chemistry of thienothiophenes <06AHC(90)125> and thienopyrimidines <06AHC(92)83> has been discussed in detail, whereas accounts of related interest highlight the field of thiaheterohelicenes <06OBC2518> as well as similar fused thiophene systems <06AG(E)8092>. 

The discrepancy between the number of well logs and the number of water chemistry results indicates that roughly 50% of well owners did not submit a water quality sample to the DENV for analysis and redeem their Water Quality Analysis Voucher over the reporting period. 

Existing chemical substances do not have to be notified. These are defined as those listed on the European Inventory of Existing Chemical Substances (EINECS) (a. 1), a list of approximately 100,000 substances reported as being supplied in the EU during the reporting period of 1 January 1971 to 18 September 1981 (389, 394). Also the DSD does not apply to medicinal products, cosmetic products, wastes, foodstuffs, pesticides, biocides and radioactive substances. 

Treatment Standards Expressed as Specified Technologies (1,3,5-TNB) Chemical lists and reporting periods (1,3-DNB)... 

This section suggests the need for frequent interaction between the study director and QA personnel. Deviations from GLP requirements noted by the QAU must be reported periodically to management and the study director. If those reports indicate that corrective action is stiU needed for any deviation from regulatory requirements, it is the study director s responsibility to assure that corrective action occurs. 

Names missing in previous editions have been added now (also marked by an asterisk), explaining for literature citations older than the beginning of the reporting period (e.g., Ref. 8). 

Some flavone structures have been revised during the reporting period. The structure of 5,8,2 -triOH-6,7-diOMe flavone (compound 131 in Table 12.1) had been ascribed to a product isolated from Scutellaria baicalensis After synthesis, it needs to be revised to 5,7,2 -triOH-6,8-diOMe flavone (compound 132, Table 12.1). " Pedunculin, earlier isolated from Tithonia species and claimed as 5,8-diOH-6,7,4 -triOMe-flavone (compound 141, Table 12.1), needs to be revised, after synthesis, to 5,7-diOH-6,8,4 -triOMe flavone = nevadensin (compound 142 in Table 12.1). " In the previous review, the compound 5,6,7,4 -tetraOH-3, 5 -diOMe had erroneously been cited as a component of Artemisia assoana. Data have now been included for the correct structure, 5,7,4 -triOH-6,3, 5 -triOMe flavone (compound 251 in Table 12.1). A further flavone reported from Ageratum conyzoides (compound 263 in... 

With the exception of sanaganone, all other compounds listed in this section exhibit a chromeno-structure between 7-OH and C-6 of ring A, whereas the furano-substitution occurs on ring B. During the reporting period, only sanaganone is a newly described compound, occurring in the root bark of Millettia (Fabaceae). ... 

Some remarks should be made regarding structures revised during the reporting period. A flavonol isolated from Glycyrrhiza lepidota, named glepidotin, had been ascribed the structure of 8-C-prenylgalangin. ° Comparison with the synthetic product and its isomer revealed that it is, in fact, 6-C-prenylgalangin (compound 78, Table 12.4). Noricaritin... 

Mr L.H. Eriksen, Feltman Research Laboratories Director, Picatinny Arsenal, has authorized approved this project. It is thru his interest, encouragement guidance that this publication is possible. The support of this project by Dr J.V.R. Kaufman, US Army Material Command Deputy Director for Plans, AMCRD, is also gratefully acknowledged. This Encyclopedia was prepared by scientists assigned to the Explosives Laboratory of FRL, Dr R.F. Walker, Chief. All reference works used, such as reports, periodicals, journal books, were made available thru the cooperation of the Scientific Technical Information Branch personnel,... 

EPA. 2002i. Toxic Substances Control Act. Chemical infomiation mles. Chemical lists and reporting periods. U.S. Environmental Protection Agency. Code of Federal Regulations. 40 CFR 712.30(d). http //ecfr.access.gpo.gov/otcgi/cfr/otfil. April 19, 2002. 

The Bureau of Radiological Health (BRH) of the Public Health Service for many years has been analyzing and evaluating environmental tritium. Several networks comprising various media have been established. Surface waters, rain, urine, and food are analyzed by the Southeastern Radiological Health Laboratory, and the results are reported periodically in Radiological Health Data and Reports. 

All reference works used (reports, periodicals, journals books) were made available to the authors thru the cooperation of PA Scientific Technical Information Branch personnel, Mr M. A. Costello, Chief. Mr John P. Noonan, Chief of the Technical Publications Section,and other personnel of the Section reviewed the manuscript in draft, checked the galley sheets, and reviewed the final copy... 

Discuss challenges solved during this report period. 

Periodic adverse experiences reports These reports must be submitted quarterly for the first 3 years after approval of the product (within 30 days of the end of the quarter) and annually (within 60 days of the anniversary of the approval date) thereafter. Periodic adverse drug experience reports should present a narrative overview and discussion of the safety information received during the reporting period. 

As described below, each of the three sections should identify all changes made during the reporting period,6 including those that were submitted in a PMA supplement or 30-Day Notice and those changes that you have not already reported in a PMA Supplement or 30-Day Notice.7... 

Information on Devices Shipped or Sold. To help the FDA assess the public health impact of the previously requested information, we are also asking that you provide us with data about the number of devices shipped or sold during the reporting period. For device implants, data regarding the number of devices actually implanted should be provided, if it is available. 

---